Moyamoya syndrome as a manifestation of varicella-associated cerebral vasculopathy—case report and review of literature

Background Varicella-associated cerebral vasculopathy (VACV) is a serious complication of Varicella zoster virus (VZV) infection. VACV has protean manifestations, with varying clinical, radiological features and prognosis. Case description Moyamoya syndrome (MMS) with VACV is reported in few cases i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Child's nervous system 2019-04, Vol.35 (4), p.601-606
Hauptverfasser: Kumar, Shishir, Pillai, Shibu V.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 606
container_issue 4
container_start_page 601
container_title Child's nervous system
container_volume 35
creator Kumar, Shishir
Pillai, Shibu V.
description Background Varicella-associated cerebral vasculopathy (VACV) is a serious complication of Varicella zoster virus (VZV) infection. VACV has protean manifestations, with varying clinical, radiological features and prognosis. Case description Moyamoya syndrome (MMS) with VACV is reported in few cases in the past. All the patients were in paediatric age group, presenting with multiple episodes of transient ischemic attacks (TIAs) and infarct. Our case was a 10-year-old Indian girl with ischemic stroke due to VACV who was treated with intravenous acyclovir. She presented 11 months later with multiple episodes of TIAs. Her angiogram showed bilateral moyamoya vasculature. Acetazolamide challenge study revealed areas of hypoperfusion. Previously reported such cases had been treated medically with steroids and antiplatelets. Most of these patients had resolution of motor symptoms after long follow-up; however, this period was marred by recurrent symptoms. Our patient underwent cerebral revascularisation procedure, following which her TIAs resolved, there was improvement in her limb power and, according to her parents, her performance in school has improved at 2-year follow-up. Conclusion MMS can be a manifestation of VACV and should be suspected in paediatric patient of non-east Asian population. These patients require treatment with intravenous acyclovir to inactivate the virus. Those with TIAs should undergo cerebral revascularisation procedures. Medical management should be reserved for patients with adequate collaterals.
doi_str_mv 10.1007/s00381-019-04091-6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2186141499</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2186141499</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-98b1a8e9c0bef4707874ffc41cbda149b193839c72de51c140297f898aace7303</originalsourceid><addsrcrecordid>eNp9kMFO3TAQRa0KVF6BH2CBvGTjdibOe7GXFYK2EhUbWFsTZ9IGJfGrnYCy60fwhf0SDA9YdjGake6dI90rxAnCZwSoviQAbVABWgUlWFSbD2KFpdYK9Br2xAqK9UZVWTsQn1K6A8C1KexHcaDBQD6LlVh-hoWGPDItYxPDwJKSJDnQ2LWcJpq6MMrQynuKnee-J0UpBd_RxI30HLmO1Gc1-bkPW5p-L__-PnpKLCNvQ5wkjU0-7zt-eMb03cSRpjnykdhvqU98_LoPxe3lxc35d3V1_e3H-dcr5bXFSVlTIxm2HmpuywoqU5Vt60v0dUNY2hqtNtr6qmh4jR5LKGzVGmuIPFca9KE423G3MfyZcyQ3dOklychhTq5As8Eyk2y2FjurjyGlyK3bxm6guDgE91y521XucuXupXK3yU-nr_y5Hrh5f3nrOBv0zpCyNP7i6O7CHMec-X_YJ0Mkj98</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2186141499</pqid></control><display><type>article</type><title>Moyamoya syndrome as a manifestation of varicella-associated cerebral vasculopathy—case report and review of literature</title><source>SpringerLink Journals</source><creator>Kumar, Shishir ; Pillai, Shibu V.</creator><creatorcontrib>Kumar, Shishir ; Pillai, Shibu V.</creatorcontrib><description>Background Varicella-associated cerebral vasculopathy (VACV) is a serious complication of Varicella zoster virus (VZV) infection. VACV has protean manifestations, with varying clinical, radiological features and prognosis. Case description Moyamoya syndrome (MMS) with VACV is reported in few cases in the past. All the patients were in paediatric age group, presenting with multiple episodes of transient ischemic attacks (TIAs) and infarct. Our case was a 10-year-old Indian girl with ischemic stroke due to VACV who was treated with intravenous acyclovir. She presented 11 months later with multiple episodes of TIAs. Her angiogram showed bilateral moyamoya vasculature. Acetazolamide challenge study revealed areas of hypoperfusion. Previously reported such cases had been treated medically with steroids and antiplatelets. Most of these patients had resolution of motor symptoms after long follow-up; however, this period was marred by recurrent symptoms. Our patient underwent cerebral revascularisation procedure, following which her TIAs resolved, there was improvement in her limb power and, according to her parents, her performance in school has improved at 2-year follow-up. Conclusion MMS can be a manifestation of VACV and should be suspected in paediatric patient of non-east Asian population. These patients require treatment with intravenous acyclovir to inactivate the virus. Those with TIAs should undergo cerebral revascularisation procedures. Medical management should be reserved for patients with adequate collaterals.</description><identifier>ISSN: 0256-7040</identifier><identifier>EISSN: 1433-0350</identifier><identifier>DOI: 10.1007/s00381-019-04091-6</identifier><identifier>PMID: 30805822</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Case-Based Update ; Medicine ; Medicine &amp; Public Health ; Neurosciences ; Neurosurgery</subject><ispartof>Child's nervous system, 2019-04, Vol.35 (4), p.601-606</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-98b1a8e9c0bef4707874ffc41cbda149b193839c72de51c140297f898aace7303</citedby><cites>FETCH-LOGICAL-c391t-98b1a8e9c0bef4707874ffc41cbda149b193839c72de51c140297f898aace7303</cites><orcidid>0000-0002-6725-1707</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00381-019-04091-6$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00381-019-04091-6$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30805822$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kumar, Shishir</creatorcontrib><creatorcontrib>Pillai, Shibu V.</creatorcontrib><title>Moyamoya syndrome as a manifestation of varicella-associated cerebral vasculopathy—case report and review of literature</title><title>Child's nervous system</title><addtitle>Childs Nerv Syst</addtitle><addtitle>Childs Nerv Syst</addtitle><description>Background Varicella-associated cerebral vasculopathy (VACV) is a serious complication of Varicella zoster virus (VZV) infection. VACV has protean manifestations, with varying clinical, radiological features and prognosis. Case description Moyamoya syndrome (MMS) with VACV is reported in few cases in the past. All the patients were in paediatric age group, presenting with multiple episodes of transient ischemic attacks (TIAs) and infarct. Our case was a 10-year-old Indian girl with ischemic stroke due to VACV who was treated with intravenous acyclovir. She presented 11 months later with multiple episodes of TIAs. Her angiogram showed bilateral moyamoya vasculature. Acetazolamide challenge study revealed areas of hypoperfusion. Previously reported such cases had been treated medically with steroids and antiplatelets. Most of these patients had resolution of motor symptoms after long follow-up; however, this period was marred by recurrent symptoms. Our patient underwent cerebral revascularisation procedure, following which her TIAs resolved, there was improvement in her limb power and, according to her parents, her performance in school has improved at 2-year follow-up. Conclusion MMS can be a manifestation of VACV and should be suspected in paediatric patient of non-east Asian population. These patients require treatment with intravenous acyclovir to inactivate the virus. Those with TIAs should undergo cerebral revascularisation procedures. Medical management should be reserved for patients with adequate collaterals.</description><subject>Case-Based Update</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neurosciences</subject><subject>Neurosurgery</subject><issn>0256-7040</issn><issn>1433-0350</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kMFO3TAQRa0KVF6BH2CBvGTjdibOe7GXFYK2EhUbWFsTZ9IGJfGrnYCy60fwhf0SDA9YdjGake6dI90rxAnCZwSoviQAbVABWgUlWFSbD2KFpdYK9Br2xAqK9UZVWTsQn1K6A8C1KexHcaDBQD6LlVh-hoWGPDItYxPDwJKSJDnQ2LWcJpq6MMrQynuKnee-J0UpBd_RxI30HLmO1Gc1-bkPW5p-L__-PnpKLCNvQ5wkjU0-7zt-eMb03cSRpjnykdhvqU98_LoPxe3lxc35d3V1_e3H-dcr5bXFSVlTIxm2HmpuywoqU5Vt60v0dUNY2hqtNtr6qmh4jR5LKGzVGmuIPFca9KE423G3MfyZcyQ3dOklychhTq5As8Eyk2y2FjurjyGlyK3bxm6guDgE91y521XucuXupXK3yU-nr_y5Hrh5f3nrOBv0zpCyNP7i6O7CHMec-X_YJ0Mkj98</recordid><startdate>20190405</startdate><enddate>20190405</enddate><creator>Kumar, Shishir</creator><creator>Pillai, Shibu V.</creator><general>Springer Berlin Heidelberg</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6725-1707</orcidid></search><sort><creationdate>20190405</creationdate><title>Moyamoya syndrome as a manifestation of varicella-associated cerebral vasculopathy—case report and review of literature</title><author>Kumar, Shishir ; Pillai, Shibu V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-98b1a8e9c0bef4707874ffc41cbda149b193839c72de51c140297f898aace7303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Case-Based Update</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neurosciences</topic><topic>Neurosurgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kumar, Shishir</creatorcontrib><creatorcontrib>Pillai, Shibu V.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Child's nervous system</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kumar, Shishir</au><au>Pillai, Shibu V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Moyamoya syndrome as a manifestation of varicella-associated cerebral vasculopathy—case report and review of literature</atitle><jtitle>Child's nervous system</jtitle><stitle>Childs Nerv Syst</stitle><addtitle>Childs Nerv Syst</addtitle><date>2019-04-05</date><risdate>2019</risdate><volume>35</volume><issue>4</issue><spage>601</spage><epage>606</epage><pages>601-606</pages><issn>0256-7040</issn><eissn>1433-0350</eissn><abstract>Background Varicella-associated cerebral vasculopathy (VACV) is a serious complication of Varicella zoster virus (VZV) infection. VACV has protean manifestations, with varying clinical, radiological features and prognosis. Case description Moyamoya syndrome (MMS) with VACV is reported in few cases in the past. All the patients were in paediatric age group, presenting with multiple episodes of transient ischemic attacks (TIAs) and infarct. Our case was a 10-year-old Indian girl with ischemic stroke due to VACV who was treated with intravenous acyclovir. She presented 11 months later with multiple episodes of TIAs. Her angiogram showed bilateral moyamoya vasculature. Acetazolamide challenge study revealed areas of hypoperfusion. Previously reported such cases had been treated medically with steroids and antiplatelets. Most of these patients had resolution of motor symptoms after long follow-up; however, this period was marred by recurrent symptoms. Our patient underwent cerebral revascularisation procedure, following which her TIAs resolved, there was improvement in her limb power and, according to her parents, her performance in school has improved at 2-year follow-up. Conclusion MMS can be a manifestation of VACV and should be suspected in paediatric patient of non-east Asian population. These patients require treatment with intravenous acyclovir to inactivate the virus. Those with TIAs should undergo cerebral revascularisation procedures. Medical management should be reserved for patients with adequate collaterals.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>30805822</pmid><doi>10.1007/s00381-019-04091-6</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-6725-1707</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0256-7040
ispartof Child's nervous system, 2019-04, Vol.35 (4), p.601-606
issn 0256-7040
1433-0350
language eng
recordid cdi_proquest_miscellaneous_2186141499
source SpringerLink Journals
subjects Case-Based Update
Medicine
Medicine & Public Health
Neurosciences
Neurosurgery
title Moyamoya syndrome as a manifestation of varicella-associated cerebral vasculopathy—case report and review of literature
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T21%3A02%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Moyamoya%20syndrome%20as%20a%20manifestation%20of%20varicella-associated%20cerebral%20vasculopathy%E2%80%94case%20report%20and%20review%20of%20literature&rft.jtitle=Child's%20nervous%20system&rft.au=Kumar,%20Shishir&rft.date=2019-04-05&rft.volume=35&rft.issue=4&rft.spage=601&rft.epage=606&rft.pages=601-606&rft.issn=0256-7040&rft.eissn=1433-0350&rft_id=info:doi/10.1007/s00381-019-04091-6&rft_dat=%3Cproquest_cross%3E2186141499%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2186141499&rft_id=info:pmid/30805822&rfr_iscdi=true